Search details
1.
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients.
Mult Scler
; 28(12): 1937-1943, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35723265
2.
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry.
Eur J Neurol
; 29(4): 1082-1090, 2022 04.
Article
in English
| MEDLINE | ID: mdl-33724638
3.
Adolescents and adults with Fontan circulation: insights from the PREpArE-Fontan registry.
Cardiol Young
; 32(4): 597-605, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34294186
4.
Validation of two predictive models for survival in pulmonary arterial hypertension.
Eur Respir J
; 46(1): 152-64, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25837032
5.
Electronic health record data for assessing risk of hospitalization for COVID-19: Methodological considerations applied to multiple sclerosis.
Mult Scler Relat Disord
; 71: 104512, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36716576
6.
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of mild-to-moderate COVID-19 in multiple sclerosis: A retrospective cohort study.
Mult Scler Relat Disord
; 79: 104943, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37716211
7.
The socioeconomic impact of disability progression in multiple sclerosis: A retrospective cohort study of the German NeuroTransData (NTD) registry.
Mult Scler J Exp Transl Clin
; 9(3): 20552173231187810, 2023.
Article
in English
| MEDLINE | ID: mdl-37529629
8.
Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical records.
Front Neurol
; 14: 1253557, 2023.
Article
in English
| MEDLINE | ID: mdl-38130836
9.
Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
Mult Scler Relat Disord
; 68: 104245, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36306609
10.
Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study.
Front Neurol
; 13: 863105, 2022.
Article
in English
| MEDLINE | ID: mdl-35614917
11.
Understanding the impacts of COVID-19 pandemic in people with multiple sclerosis treated with ocrelizumab.
Mult Scler Relat Disord
; 55: 103203, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34411984
12.
Five-Year outcomes of patients enrolled in the REVEAL Registry.
Chest
; 148(4): 1043-54, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26066077
13.
European Congress of Vaccinology in Armed Forces, Paris, France, 16-17 October 2006.
Mil Med
; 173(11): vi-ix, 2008 Nov.
Article
in English
| MEDLINE | ID: mdl-19055174
14.
Deletion of the Correia element in the mtr gene complex of Neisseria meningitidis.
J Med Microbiol
; 59(Pt 9): 1055-1060, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20538893
15.
Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region.
J Infect
; 59(2): 104-14, 2009 Aug.
Article
in English
| MEDLINE | ID: mdl-19576638
16.
Meningitis epidemics in Africa: a brief overview.
Vaccine
; 25 Suppl 1: A3-7, 2007 Sep 03.
Article
in English
| MEDLINE | ID: mdl-17643560
Results
1 -
16
de 16
1
Next >
>>